Birth control pill has lasting protective effects against endometrial cancer
the ONA take:
A new study from researchers at the University of Oxford in the United Kingdom reports that oral contraceptives protect against endometrial cancer, and the protective benefit lasts for many years after women stop taking the pills.
Previous studies linked the use of the birth control pill with reduced incidence of endometrial cancer, but whether this continued after the use is discontinued was unknown.
In this study, the researchers used a dataset that included 27,276 women with endometrial cancer and 115,743 women without the disease from 36 epidemiological studies.
They calculated that the risk of endometrial cancer was reduced by approximately 25% for every 5 years of use. Furthermore, the reduced risk persisted for more than 30 years after birth control pills were discontinued.
The decrease in the amount of estrogen birth control pills also did not diminish the protective effects of oral contraceptive use.
An estimated 400,000 cases of endometrial cancer were prevented in developed countries due to the use of birth control pills between 1965 and 2014, with approximately 200,000 cases prevented after 2005.
Oral contraceptives protect against endometrial cancer, and the protective benefit lasts for many years after women stop taking the pills.
Sign Up for Free e-newsletters
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Breast Cancer Deaths Decrease Sharply Since 2000
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|